Can-Fite BioPharma Ltd.CANFNYSE
Loading
EPS Growth Under PressureDecelerating
Percentile Rank71
3Y CAGR+11.2%
5Y CAGR+27.7%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+11.2%/yr
vs -5.6%/yr prior
5Y CAGR
+27.7%/yr
Recent deceleration
Acceleration
+16.8pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
3.4x
Strong expansion
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 40.00% |
| 2023 | 52.00% |
| 2022 | 58.33% |
| 2021 | 29.08% |
| 2020 | 71.80% |
| 2019 | 11.76% |
| 2018 | 10.53% |
| 2017 | 36.67% |
| 2016 | -11.11% |
| 2015 | 22.86% |